New hope for rare brain fungus: experimental drug olorofim enters trial
NCT ID NCT07385638
First seen Feb 04, 2026 · Last updated Apr 29, 2026 · Updated 9 times
Summary
This study tests an experimental drug called olorofim in people recently diagnosed with coccidioidal meningitis, a rare fungal infection of the brain and spinal cord. About 12 adults will take the drug for 6 months to see if it is safe and helps control the infection. The goal is to manage the disease, not cure it, and participants may continue treatment through a special access program afterward.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COCCIDIOIDAL MENINGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Banner University Medical Center
Tucson, Arizona, 85719, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.